OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (4)

  1. Seon Young Kim, Hee Jin Huh. Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia. Ann Lab Med 2023;43:323
    https://doi.org/10.3343/alm.2023.43.4.323
  2. Jin Ju Kim, Soo-Jeong Kim, Seoyoung Lim, Seung-Tae Lee, Jong Rak Choi, Saeam Shin, Doh Yu Hwang. Enhancing mutation detection in multiple myeloma with an error-corrected ultra-sensitive NGS assay without plasma cell enrichment. Cancer Cell Int 2024;24
    https://doi.org/10.1186/s12935-024-03470-7
  3. İbrahim Halil Erdoğdu, Seda Örenay-Boyacıoğlu, Olcay Boyacıoğlu, Nesibe Kahraman-Çetin, Füruzan Kacar-Döger, İrfan Yavaşoğlu, Ali Zahit Bolaman. Evaluation of New Generation Sequencing (NGS)-Based Somatic Gene Variations and Real-Time Polymerase Chain Reaction (PCR)-Based Gene Fusions in Elderly and Young Acute Leukemia Patients: A Retrospective View. JPM 2024;14:140
    https://doi.org/10.3390/jpm14020140
  4. Yu Jeong Choi, Hye Won Kook, Seung-Tae Lee, Jaewoo Song, Jong Rak Choi, June-Won Cheong, Saeam Shin. The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report. Leukemia & Lymphoma 2024:1
    https://doi.org/10.1080/10428194.2024.2385498
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd